Abstract
Background
Observational studies suggest that gut microbiome (GM) may contribute to acute anterior uveitis (AAU) development, but causality remains unclear. This study was conducted to test whether specific GM taxa were causally associated with AAU.
Methods
The GM data were obtained from the DMP, which included 7738 individuals’ faecal samples and an analysis of host genotype-taxa abundance associations. The AAU data were derived from the FinnGen Consortium (8624 cases and 473,095 controls). We primarily employed the inverse-variance weighted method, complemented by supplementary sensitivity analyses.
Results
Higher abundance of Lachnospiraceae noname (OR = 0.86, 95% CI 0.81–0.91, P = 5.7 × 10-8), Alistipes finegoldii (OR = 0.87, 95% CI 0.78–0.96, P = 0.008), Erysipelotrichaceae (OR = 0.90, 95% CI 0.81–0.99, P = 0.037), Erysipelotrichia (OR = 0.90, 95% CI 0.81–0.99, P = 0.037), Erysipelotrichales (OR = 0.90, 95% CI 0.81–0.99, P = 0.037), and Bacteroides ovatus (OR = 0.93, 95% CI 0.87–1.00, P = 0.039) predicted a lower AAU risk. Conversely, higher abundance of Bifidobacterium catenulatum (OR = 1.06, 95% CI: 1.02–1.10, P = 0.005), Bacteroides coprocola (OR = 1.11, 95% CI: 1.02–1.21, P = 0.014), Parabacteroides unclassified (OR = 1.12, 95% CI 1.03–1.22, P = 0.010), and Prevotella (OR = 1.15, 95% CI: 1.01–1.29, P = 0.029) predicted a higher AAU risk. The results also showed a reverse causation from AAU to Bifidobacterium catenulatum (OR = 1.39, 95% CI: 1.03–1.86, P = 0.005).
Conclusion
This study suggests that specific GM is causally associated with AAU risk, warranting more mechanistic validation and clinical trials.
This is a preview of subscription content, access via your institution
Access options





Similar content being viewed by others
Data availability
Summary statistics of gut microbiome GWAS were obtained from the GWAS Catalog https://www.ebi.ac.uk/gwas/publications/35115690, and acute anterior uveitis GWAS summary statistics were retrieved from the FinnGen database https://www.finngen.fi/en/access_results.
References
Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26:2–16.
Goodchild C, O’Rourke M, Haroon M, FitzGerald O, Murphy CC. 5-year longitudinal study of clinical and patient-reported outcomes in acute anterior uveitis. Eye. 2021;35:651–8.
Zhuang Z, Wang Y, Zhu G, Gu Y, Mao L, Hong M, et al. Imbalance of Th17/Treg cells in pathogenesis of patients with human leukocyte antigen B27 associated acute anterior uveitis. Sci Rep. 2017;7:40414.
Huang XF, Brown MA. Progress in the genetics of uveitis. Genes Immun. 2022;23:57–65.
Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, et al. The ocular immunology and uveitis foundation preferred practice patterns of uveitis management. Surv Ophthalmol. 2016;61:1–17.
Lin P, Suhler EB, Rosenbaum JT. The future of uveitis treatment. Ophthalmology 2014;121:365–76.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr., Brézin AP, Chee SP, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitiS (FOCUS) initiative. Ophthalmology 2018;125:757–73.
Huang X, Ye Z, Cao Q, Su G, Wang Q, Deng J, et al. Gut microbiota composition and fecal metabolic phenotype in patients with acute anterior uveitis. Investig Ophthalmol Vis Sci. 2018;59:1523–31.
Essex M, Rios Rodriguez V, Rademacher J, Proft F, Löber U, Markó L, et al. Shared and distinct gut microbiota in spondyloarthritis, acute anterior uveitis, and Crohn’s disease. Arthritis Rheumatol. 2024;76:48–58.
Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell 2016;164:337–40.
Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23:38–54.
Wang Q, Yi S, Su G, Du Z, Pan S, Huang X, et al. Changes in the gut microbiome contribute to the development of behcet’s disease via adjuvant effects. Front Cell Dev Biol. 2021;9:716760.
Pingault JB, O’Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet. 2018;19:566–80.
Plotnikov D, Guggenheim JA. Mendelian randomisation and the goal of inferring causation from observational studies in the vision sciences. Ophthalmic Physiol Opt. 2019;39:11–25.
Hong JB, Chen YX, Su ZY, Chen XY, Lai YN, Yang JH. Causal association of juvenile idiopathic arthritis or JIA-associated uveitis and gut microbiota: a bidirectional two-sample Mendelian randomisation study. Front Immunol. 2024;15:1356414.
Morris AH, Bohannan BJM. Estimates of microbiome heritability across hosts. Nat Microbiol. 2024;9:3110–9.
Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA 2021;326:1614–21.
Lopera-Maya EA, Kurilshikov A, van der Graaf A, Hu S, Andreu-Sánchez S, Chen L, et al. Effect of host genetics on the gut microbiome in 7738 participants of the Dutch Microbiome Project. Nat Genet. 2022;54:143–51.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023;613:508–18.
Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51:600–5.
Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 2022;54:52–61.
Mi Y, Zhu Q, Zheng X, Wan M. The protective role of water intake in age-related eye diseases: insights from a Mendelian randomization study. Food Funct. 2024;15:5147–57.
Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics 2019;35:4851–3.
Bowden J, Spiller W, Del Greco MF, Sheehan N, Thompson J, Minelli C, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. 2018;47:2100.
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.
Mi Y, Chen K, Lin S, Tong L, Zhou J, Wan M. Lactobacillaceae-mediated eye-brain-gut axis regulates high myopia-related anxiety: from the perspective of predictive, preventive, and personalized medicine. EPMA J. 2024;15:573–85.
Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081.
Panagiotou OA, Ioannidis JP. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol. 2012;41:273–86.
Slob EAW, Burgess S. A comparison of robust Mendelian randomization methods using summary data. Genet Epidemiol. 2020;44:313–29.
Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377–89.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.
Burgess S, Zuber V, Gkatzionis A, Foley CN. Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid. Int J Epidemiol. 2018;47:1242–54.
Xue H, Shen X, Pan W. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021;108:1251–69.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.
Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 2017;28:30–42.
Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926–40.
Wang Q, Wu S, Ye X, Tan S, Huang F, Su G, et al. Gut microbial signatures and their functions in Behcet’s uveitis and Vogt-Koyanagi-Harada disease. J Autoimmun. 2023;137:103055.
Zhong Z, Su G, Yang P. Risk factors, clinical features and treatment of Behçet’s disease uveitis. Prog Retin Eye Res. 2023;97:101216.
Liu C, Wang X, Cao X. IL-10: a key regulator and potential therapeutic target in uveitis. Cell Immunol. 2024;405-406:104885.
Burrello C, Garavaglia F, Cribiù FM, Ercoli G, Lopez G, Troisi J, et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat Commun. 2018;9:5184.
Robinson PC, Claushuis TA, Cortes A, Martin TM, Evans DM, Leo P, et al. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol. 2015;67:140–51.
Chen W, Zhao B, Jiang R, Zhang R, Wang Y, Wu H, et al. Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Curr Mol Med. 2015;15:543–9.
Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8:573.
Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: a review. Clin Exp Ophthalmol. 2019;47:418–22.
Huang YF, Zhang WM, Wei ZS, Huang H, Mo QY, Shi DL, et al. Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: a bidirectional Mendelian randomization study. Front Immunol. 2023;14:1136169.
Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21:28.
Li Y, Hong M, Huang X, Zhong L, Gu Y. Wang D, et al. PD-1 polymorphisms are associated with susceptibility of acute anterior uveitis in chinese population. DNA Cell Biol. 2019;38:121–8.
Yang C, Mogno I, Contijoch EJ, Borgerding JN, Aggarwala V, Li Z, et al. Fecal IgA levels are determined by strain-level differences in bacteroides ovatus and are modifiable by gut microbiota manipulation. Cell Host Microbe. 2020;27:467–75.e6.
Ihekweazu FD, Engevik MA, Ruan W, Shi Z, Fultz R, Engevik KA, et al. Bacteroides ovatus promotes IL-22 production and reduces trinitrobenzene sulfonic acid-driven colonic inflammation. Am J Pathol. 2021;191:704–19.
Sprenkels SH, Uksila J, Vainionpää R, Toivanen P, Feltkamp TE. IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis. Clin Rheumatol. 1996;15:52–6.
Huang JC, Schleisman M, Choi D, Mitchell C, Watson L, Asquith M, et al. Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis. Ocul Immunol Inflamm. 2021;29:558–65.
O’Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2017;2:17057.
Wu PH, Tseng YF, Liu W, Chuang YS, Tai CJ, Tung CW, et al. Exploring the relationship between gut microbiome composition and blood indole-3-acetic acid in hemodialysis patients. Biomedicines 2024;12:148.
Ye Z, Wu C, Zhang N, Du L, Cao Q, Huang X, et al. Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease. Gut Microbes. 2020;11:539–55.
Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, et al. A metagenomic study of the gut microbiome in Behcet’s disease. Microbiome 2018;6:135.
Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One. 2014;9:e105684.
Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013;2:e01202.
Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol. 2021;19:585–99.
Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28:405–40.
Kim J, Choi SH, Kim YJ, Jeong HJ, Ryu JS, Lee HJ, et al. Clinical effect of IRT-5 probiotics on immune modulation of autoimmunity or alloimmunity in the eye. Nutrients. 2017;9:166.
Westfall S, Caracci F, Zhao D, Wu QL, Frolinger T, Simon J, et al. Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors. Brain Behav Immun. 2021;91:350–68.
Shen X, Du J, Guan W, Zhao Y. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance. Expert Rev Clin Immunol. 2014;10:353–62.
van der Houwen TB, van Laar JAM, Kappen JH, van Hagen PM, de Zoete MR, van Muijlwijk GH, et al. Behçet’s disease under microbiotic surveillance? A combined analysis of two cohorts of behçet’s disease patients. Front Immunol. 2020;11:1192.
Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, et al. Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet’s disease. PLoS ONE. 2016;11:e0153746.
Hall N, Douglas VP, Ivanov A, Ross C, Elze T, Kempen JH, et al. The epidemiology and risk factors for the progression of sympathetic ophthalmia in the United States: an IRIS registry analysis. Am J Ophthalmol. 2024;258:208–16.
Wang Q, Ma J, Gong Y, Zhu L, Tang H, Ye X, et al. Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis. Cell Discov. 2024;10:47.
Acknowledgements
We thank all participants and investigators from the Dutch Microbiome Project and FinnGen study.
Funding
This work was supported by a grant from the Wenzhou Science & Technology Bureau (Grant No. Y20210997).
Author information
Authors and Affiliations
Contributions
YM conceptualized and designed the study. YM performed the data analysis, while LC validated the analytical findings. YM NL and MW drafted and substantially revised the manuscript. All authors reviewed and approved the final version of the manuscript for publication.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mi, Y., Chen, L., Liao, N. et al. Mendelian randomization analysis revealed a gut microbiota-eye axis in acute anterior uveitis. Eye 39, 1562–1570 (2025). https://doi.org/10.1038/s41433-025-03715-3
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-03715-3


